Optimizing the expression of an anti-Leishmania nanobody ‘ALNb18’ produced free or fused with super folder GFP

References

• Hamers-Casterman C, Atarhouch T, Muyldermans S, et al. Naturally occurring antibodies devoid of light chains. Nature. 1993;363(6428):446–448.
   PubMed Web of Science ®Google Scholar
• Arbabi Ghahroudi M, Desmyter A, Wyns L, et al. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett. 1997;414(3):521–526.
   PubMed Web of Science ®Google Scholar
• Arbabi-Ghahroudi M. Camelid single-domain antibodies: historical perspective and future outlook. Front Immunol. 2017;8:1589–1589.
   PubMed Web of Science ®Google Scholar
• Bannas P, Hambach J, Koch-Nolte F. Nanobodies and Nanobody-Based human heavy chain antibodies as antitumor therapeutics. Front Immunol. 2017;8:1603.
   PubMed Web of Science ®Google Scholar
• Saerens D, Ghassabeh GH, Muyldermans S. Single-domain antibodies as building blocks for novel therapeutics. Curr Opin Pharmacol. 2008;8(5):600–608.
   PubMed Web of Science ®Google Scholar
• Van MV, Fujimori T, Bintu L. Nanobody-mediated control of gene expression and epigenetic memory. Nat Commun. 2021;12(1):537.
   PubMed Web of Science ®Google Scholar
• Wesolowski J, Alzogaray V, Reyelt J, et al. Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol. 2009;198(3):157–174.
   PubMed Web of Science ®Google Scholar
• de Marco A. Recombinant expression of nanobodies and nanobody-derived immunoreagents. Protein Expr Purif. 2020;172:105645.
   PubMed Web of Science ®Google Scholar
• Veggiani G, de Marco A. Improved quantitative and qualitative production of single-domain intrabodies mediated by the co-expression of Erv1p sulfhydryl oxidase. Protein Expr Purif. 2011;79(1):111–114.
   PubMed Web of Science ®Google Scholar
• Kariuki CK, Magez S. Improving the yield of recalcitrant nanobodies® by simple modifications to the standard protocol. Protein Expr Purif. 2021;185:105906.
   PubMed Web of Science ®Google Scholar
• Van Noi N, Chung Y-C. Optimization of expression and purification of recombinant S1 domain of the porcine epidemic diarrhea virus spike (PEDV- S1) protein in Escherichia coli. Biotechnology & Biotechnological Equipment. 2017;31(3):619–629.
   Web of Science ®Google Scholar
• Salema V, Fernandez LA. High yield purification of nanobodies from the periplasm of E. coli as fusions with the maltose binding protein. Protein Expr Purif. 2013;91(1):42–48.
   PubMed Web of Science ®Google Scholar
• Mitchell LS, Colwell LJ. Comparative analysis of nanobody sequence and structure data. Proteins. 2018b;86(7):697–706.
   PubMed Web of Science ®Google Scholar
• Mitchell LS, Colwell LJ. Analysis of nanobody paratopes reveals greater diversity than classical antibodies. Protein Eng Des Sel. 2018a;31(7-8):267–275.
   PubMed Web of Science ®Google Scholar
• Zimmermann I, Egloff P, Hutter CA, et al. Synthetic single domain antibodies for the conformational trapping of membrane proteins. Elife. 2018;7:34317.
   PubMed Web of Science ®Google Scholar
• Muhjazi G, Gabrielli AF, Ruiz-Postigo JA, et al. Cutaneous leishmaniasis in syria: a review of available data during the war years: 2011-2018. PLoS Negl Trop Dis. 2019;13(12):e0007827.
   PubMed Web of Science ®Google Scholar
• Alvar J, Velez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5):e35671.
   PubMed Web of Science ®Google Scholar
• Rioux JA, Dereure J, Khiami A, et al. [Ecoepidemiology of leishmaniasis in syria. 1. Leishmania major yakimoff and schokhor (Kinetoplastida-Trypanosomatidae) infestation of psammomys obesus cretzschmar (Rodentia-Gerbillidae)]. Ann Parasitol Hum Comp. 1990;65(5-6):203–207.
   PubMedGoogle Scholar
• Ruiz-Postigo JA, Grouta L, Jaina S. Global leishmaniasis surveillance, 2017–2018, and first report on 5 additional indicators. WHO, Weekly Epidemiological Record No. 2020;25(95):265–280. https://www.who.int/publications/i/item/who-wer9525
   Google Scholar
• Alshamat EA, Kweider M, Soukkarieh C, et al. Phage-nanobody as molecular marker for the detection of Leishmania tropica. Gene Rep. 2020;19:100577.
   Web of Science ®Google Scholar
• Abu Alshamat E, Kweider M, Abbady AQ. Camel nanobodies: Promising molecular tools against leishmaniasis. Parasite Immunol. 2020;42(9):e12718.
   PubMed Web of Science ®Google Scholar
• Rosano GL, Ceccarelli EA. Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol. 2014;5:172.
   PubMed Web of Science ®Google Scholar
• Puckett LG, Dikici E, Lai S, et al. Investigation into the applicability of the centrifugal microfluidics platform for the development of protein-ligand binding assays incorporating enhanced green fluorescent protein as a fluorescent reporter. Anal Chem. 2004;76(24):7263–7268.
   PubMed Web of Science ®Google Scholar
• Shimomura O. Discovery of green fluorescent protein (GFP) (nobel lecture). Angew Chem Int Ed Engl. 2009;48(31):5590–5602.
   PubMed Web of Science ®Google Scholar
• Tsien RY. The green fluorescent protein. Annu Rev Biochem. 1998;67:509–544.
   PubMed Web of Science ®Google Scholar
• Cabantous S, Waldo GS. In vivo and in vitro protein solubility assays using split GFP. Nat Methods. 2006;3(10):845–854.
   PubMed Web of Science ®Google Scholar
• Liu M, Wang B, Wang F, et al. Soluble expression of single-chain variable fragment (scFv) in Escherichia coli using superfolder green fluorescent protein as fusion partner. Appl Microbiol Biotechnol. 2019;103(15):6071–6079.
   PubMed Web of Science ®Google Scholar
• Pedelacq JD, Cabantous S, Tran T, et al. Engineering and characterization of a superfolder green fluorescent protein. Nat Biotechnol. 2006;24(1):79–88.
   PubMed Web of Science ®Google Scholar
• Dinh T, Bernhardt TG. Using superfolder green fluorescent protein for periplasmic protein localization studies. J Bacteriol. 2011;193(18):4984–4987.
   PubMed Web of Science ®Google Scholar
• Abbady AQ, Twair A, Ali B, et al. Characterization of annexin V fusion with the superfolder GFP in liposomes binding and apoptosis detection [original research]. Front Physiol. 2017;8:317.
   PubMed Web of Science ®Google Scholar
• 31. Abbady AQ, Al-Shemali R, Mir Assaad J, et al. Generation and characterization of nanobodies against rhGH expressed as sfGFP fusion protein. Gen Comp Endocrinol. 2014;204:33–42.
   PubMed Web of Science ®Google Scholar
• Froger A, Hall JE. Transformation of plasmid DNA into E. coli using the heat shock method. J Vis Exp. 2007;(6):e253.
   PubMedGoogle Scholar
• 33. Al-Homsi L, Al-Assad JM, Kweider M, et al. Construction of pRSET-sfGFP plasmid for fusion-protein expression, purification and detection. Jordan J Biol Sci. 2012;5(4):279–288.
   Google Scholar
• Sivashanmugam A, Murray V, Cui C, et al. Practical protocols for production of very high yields of recombinant proteins using Escherichia coli. Protein Sci. 2009;18(5):936–948.
   PubMed Web of Science ®Google Scholar
• Simpson RJ. Rapid coomassie blue staining of protein gels. Cold Spring Harb Protoc. 2010;2010(4):pdb.prot5413.
   PubMedGoogle Scholar
• Haddad M, Soukkarieh C, Khalaf HE, et al. Purification of polyclonal IgG specific for camelid’s antibodies and their recombinant nanobodies. Open Life Sci. 2016;11(1):1–9.
   Web of Science ®Google Scholar
• Kelley LA, Mezulis S, Yates CM, et al. The Phyre2 web portal for protein modelling, prediction and analysis. Nat Protoc. 2015;10(6):845–858.
   PubMed Web of Science ®Google Scholar
• 38. GenScript Rare Codon Analysis Tool. 2002. 8 September. https://www.genscript.com/tools/rare-codon-analysis.
   Google Scholar
• Lefranc MP, Pommie C, Ruiz M, et al. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol. 2003;27(1):55–77.
   PubMed Web of Science ®Google Scholar
• Turner P, Holst O, Karlsson EN. Optimized expression of soluble cyclomaltodextrinase of thermophilic origin in Escherichia coli by using a soluble fusion-tag and by tuning of inducer concentration. Protein Expr Purif. 2005;39(1):54–60.
   PubMed Web of Science ®Google Scholar
• Beigi L, Karbalaei-Heidari HR, Kharrati-Kopaei M. Optimization of an extracellular zinc-metalloprotease (SVP2) expression in Escherichia coli BL21 (DE3) using response surface methodology. Protein Expr Purif. 2012;84(1):161–166.
   PubMed Web of Science ®Google Scholar
• Chambers SP, Swalley SE. Designing experiments for high-throughput protein expression. Methods Mol Biol. 2009;498:19–29.
   PubMedGoogle Scholar
• Li D, Ji F, Huang C, et al. High expression achievement of active and robust anti-beta2 microglobulin nanobodies via E. coli hosts selection. Molecules. 2019;24(16):2860.
   PubMed Web of Science ®Google Scholar
• Dvorak P, Chrast L, Nikel PI, et al. Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway. Microb Cell Fact. 2015;14:201.
   PubMed Web of Science ®Google Scholar
• Rizkia PR, Silaban S, Hasan K, et al. Effect of isopropyl-β-D-thiogalactopyranoside concentration on prethrombin-2 recombinan gene expression in Escherichia Coli ER2566. Procedia Chem. 2015;17:118–124.
   Google Scholar
• Li XL, Robbins JW, Jr., Taylor KB. The production of recombinant beta-galactosidase in Escherichia coli in yeast extract enriched medium. J Ind Microbiol. 1990;5(2-3):85–93.
   PubMedGoogle Scholar
• Nancib N, Branlant C, Boudrant J. Metabolic roles of peptone and yeast extract for the culture of a recombinant strain of Escherichia coli. J Ind Microbiol. 1991;8(3):165–169.
   PubMedGoogle Scholar
• Sahdev S, Khattar SK, Saini KS. Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies. Mol Cell Biochem. 2008;307(1-2):249–264.
   PubMed Web of Science ®Google Scholar
• Daniel E, Onwukwe GU, Wierenga RK, et al. ATGme: Open-source web application for rare codon identification and custom DNA sequence optimization. BMC Bioinformatics. 2015;16(1):303.
   PubMedGoogle Scholar
• Raab D, Graf M, Notka F, et al. The GeneOptimizer algorithm: using a sliding window approach to cope with the vast sequence space in multiparameter DNA sequence optimization. Syst Synth Biol. 2010;4(3):215–225.
   PubMedGoogle Scholar
• Wu X, Wu D, Lu Z, et al. A novel method for high-level production of TEV protease by superfolder GFP tag. J Biomed Biotechnol. 2009;2009:591923–591928. (
   PubMedGoogle Scholar
• Al-Homsi L, El-Din HN, Murad H, et al. Assessing the bioactivity of the codon optimized sfGFP-IGF1 fusion protein via interaction with IGFBP3 and induction of cell proliferation. Gene Reports. 2019;17:100496.
   Web of Science ®Google Scholar
• Stepanenko OV, Stepanenko OV, Kuznetsova IM, et al. Sensitivity of superfolder GFP to ionic agents. PLoS One. 2014;9(10):e110750.
   PubMed Web of Science ®Google Scholar
• 54. Murad H, Ali B, Makeya R, et al. Prokaryotic overexpression of TEV-rhGH and characterization of its polyclonal antibody. Gene. 2014;542(1):69–76.
   PubMed Web of Science ®Google Scholar
• 55. Rothbauer U, Zolghadr K, Tillib S, et al. Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat Methods. 2006;3(11):887–889. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17060912
   PubMed Web of Science ®Google Scholar